Saturday August 19th 2017

Staying at work and living with MS: a qualitative study of the impact of a vocational rehabilitation intervention.

Conclusions: The VR intervention was valued by people with MS who felt that after the intervention they had a greater understanding of disease related, work related and personal factors that impacted on their ability to work and they were supported to manage these by a skilled professional. The themes identified in this study help gain insight into the participants’ experience of the intervention and identify aspects that were most helpful from the participants’ perspectives. This information could be used to inform further research and service development. Implication for Rehabilitation Vocational rehabilitation can be effective in maintaining people with MS in their employment and help to remove some of the physical and emotional barriers that can develop. Employers and employees with MS…

More: 

Staying at work and living with MS: a qualitative study of the impact of a vocational rehabilitation intervention.

Leave a Comment

More from category

Researchers Co-funded by National MS Society Report on New Way to Translate Lab Findings Aimed at Re
Researchers Co-funded by National MS Society Report on New Way to Translate Lab Findings Aimed at Re

/About-the-Society/News/Researchers-Co-funded-by-National-MS-Society-Repor [Read More]

Investigators Recruiting for Study of ALKS 8700 vs. Dimethyl Fumarate in Relapsing-Remitting MS
Investigators Recruiting for Study of ALKS 8700 vs. Dimethyl Fumarate in Relapsing-Remitting MS

/About-the-Society/News/Investigators-Recruiting-for-Study-of-ALKS-8700-vs [Read More]

Statement on House Oversight and Government Reform Committee Action on the Pricing Strategies for MS
Statement on House Oversight and Government Reform Committee Action on the Pricing Strategies for MS

/About-the-Society/News/Statement-on-House-Oversight-and-Government-Reform [Read More]

Drug blocked by regulators found to improve quality of life for MS patients
Drug blocked by regulators found to improve quality of life for MS patients

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with [Read More]

House Dems launch MS drug pricing probe
House Dems launch MS drug pricing probe

Democrats from the House Committee on Oversight and Government Reform have sent letters to seven drugmakers as part of [Read More]